Sunday, October 18, 2009

FDA approves Cervarix

The FDA has approved Cervarix, a new cervical cancer vaccine. The current vaccine Gardasil is made by Merck and Cervarix is made by GlaxoSmithKline (GSK).
The FDA has approved CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10-25).
Click here to read the press release on the GSK website.

No comments:

Post a Comment